Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Messchendorp AL, Zaeck LM, Bouwmans P, van den Broek DAJ, Frölke SC, Geers D, Imhof C, Malahe SRK, Schmitz KS, Reinders J, Visscher FE, Baan CC, Bemelman FJ, Gansevoort RT, GeurtsvanKessel CH, Hemmelder MH, Hilbrands LB, Källmark H, Kapetanovic MC, Kho MML, de Vries APJ, van Zuilen AD, Reinders ME, van Baarle D, de Vries RD, Sanders JF, RECOVAC Collaborators

Open source

DOI
10.1093/cid/ciaf107
Published
2026 Feb 4
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciaf107,
  title = {Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.},
  author = {Messchendorp AL and Zaeck LM and Bouwmans P and van den Broek DAJ and Frölke SC and Geers D and Imhof C and Malahe SRK and Schmitz KS and Reinders J and Visscher FE and Baan CC and Bemelman FJ and Gansevoort RT and GeurtsvanKessel CH and Hemmelder MH and Hilbrands LB and Källmark H and Kapetanovic MC and Kho MML and de Vries APJ and van Zuilen AD and Reinders ME and van Baarle D and de Vries RD and Sanders JF and RECOVAC Collaborators},
  year = {2026},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciaf107},
  url = {https://doi.org/10.1093/cid/ciaf107}
}

RIS

TY  - JOUR
TI  - Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.
AU  - Messchendorp AL
AU  - Zaeck LM
AU  - Bouwmans P
AU  - van den Broek DAJ
AU  - Frölke SC
AU  - Geers D
AU  - Imhof C
AU  - Malahe SRK
AU  - Schmitz KS
AU  - Reinders J
AU  - Visscher FE
AU  - Baan CC
AU  - Bemelman FJ
AU  - Gansevoort RT
AU  - GeurtsvanKessel CH
AU  - Hemmelder MH
AU  - Hilbrands LB
AU  - Källmark H
AU  - Kapetanovic MC
AU  - Kho MML
AU  - de Vries APJ
AU  - van Zuilen AD
AU  - Reinders ME
AU  - van Baarle D
AU  - de Vries RD
AU  - Sanders JF
AU  - RECOVAC Collaborators
PY  - 2026
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciaf107
UR  - https://doi.org/10.1093/cid/ciaf107
ER  - 

APA

AL, M., LM, Z., P, B., DAJ, V. D. B., SC, F., D, G., C, I., SRK, M., KS, S., J, R., FE, V., CC, B., FJ, B., RT, G., CH, G., MH, H., LB, H., H, K., MC, K., MML, K., APJ, D. V., AD, V. Z., ME, R., D, V. B., RD, D. V., JF, S., & Collaborators, R. (2026). Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciaf107

Source records